US 12018045
17-beta-hydroxywithanolides and use thereof in treating cancer
granted A61KA61K31/404A61K31/58
Quick answer
US patent 12018045 (17-beta-hydroxywithanolides and use thereof in treating cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/404, A61K31/58, A61K31/635, A61K45/06